Literature DB >> 35146060

Depression and Apathy across Different Variants of Progressive Supranuclear Palsy.

Sarah M Bower1, Stephen D Weigand2, Farwa Ali1, Heather M Clark1, Hugo Botha1, Julie A Stierwalt1, Jennifer L Whitwell3, Keith A Josephs1.   

Abstract

BACKGROUND: Apathy and depression commonly occur in patients with progressive supranuclear palsy (PSP)-Richardson's syndrome variant; depression often requiring treatment. Little is known, however, about apathy and depression among other PSP variants.
METHODS: We prospectively studied 97 newly diagnosed PSP patients. All were classified into a PSP variant using the 2017 Movement Disorder Society-PSP criteria and administered the Geriatric Depression and Apathy Evaluation Scales. Differences in apathy and depression frequency and severity across six variants, and secondarily across PSP-Richardson's syndrome, PSP-Cortical and PSP-Subcortical, were analyzed using ANCOVA and linear regression adjusting for disease severity.
RESULTS: Depression (55%) was more common than apathy (12%). PSP-Speech/Language (PSP-SL) variant had the lowest depression frequency (13%) and lower depression scores than the other variants. No differences in apathy frequency/severity were identified.
CONCLUSION: PSP-SL patients may have less depression compared to PSP-Richardson's syndrome and other PSP variants.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  PSP; PSP‐cortical; Richardson syndrome; speech apraxia; variants

Year:  2021        PMID: 35146060      PMCID: PMC8810431          DOI: 10.1002/mdc3.13396

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  21 in total

Review 1.  Principles of multilevel modelling.

Authors:  S Greenland
Journal:  Int J Epidemiol       Date:  2000-02       Impact factor: 7.196

2.  Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Authors:  Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

3.  Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.

Authors:  Gesine Respondek; Max-Joseph Grimm; Ines Piot; Thomas Arzberger; Yaroslau Compta; Elisabet Englund; Leslie W Ferguson; Ellen Gelpi; Sigrun Roeber; Armin Giese; Murray Grossman; David J Irwin; Wassilios G Meissner; Christer Nilsson; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Günter U Höglinger
Journal:  Mov Disord       Date:  2019-09-30       Impact factor: 10.338

4.  Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.

Authors:  John C Morgan; Xiaolan Ye; Jennifer A Mellor; Keisha J Golden; Jorge Zamudio; Louis A Chiodo; Yanjun Bao; Tao Xie
Journal:  J Neurol Sci       Date:  2020-12-25       Impact factor: 3.181

5.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

6.  Gray matter correlates of behavioral severity in progressive supranuclear palsy.

Authors:  Keith A Josephs; Jennifer L Whitwell; Scott D Eggers; Matthew L Senjem; Clifford R Jack
Journal:  Mov Disord       Date:  2011-01-12       Impact factor: 10.338

7.  Motor, cognitive and behavioral differences in MDS PSP phenotypes.

Authors:  Marina Picillo; Sofia Cuoco; Maria Francesca Tepedino; Arianna Cappiello; Giampiero Volpe; Roberto Erro; Gabriella Santangelo; Maria Teresa Pellecchia; Paolo Barone
Journal:  J Neurol       Date:  2019-04-15       Impact factor: 4.849

Review 8.  Diagnosis and management of progressive supranuclear palsy.

Authors:  I Litvan
Journal:  Semin Neurol       Date:  2001       Impact factor: 3.420

9.  Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes.

Authors:  B Borroni; M Turla; V Bertasi; C Agosti; N Gilberti; A Padovani
Journal:  Arch Gerontol Geriatr       Date:  2007-08-31       Impact factor: 3.250

10.  A Systematic Review of Apathy and Depression in Progressive Supranuclear Palsy.

Authors:  Joshua Flavell; Peter J Nestor
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-02-11       Impact factor: 2.680

View more
  1 in total

Review 1.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.